Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Asthma | 7 | 2021 | 345 | 2.560 |
Why?
|
Medicare | 8 | 2022 | 319 | 1.880 |
Why?
|
Hearing Loss | 4 | 2019 | 154 | 1.860 |
Why?
|
Stroke | 15 | 2022 | 2163 | 1.820 |
Why?
|
Anti-Asthmatic Agents | 4 | 2019 | 56 | 1.490 |
Why?
|
Electronic Health Records | 5 | 2022 | 374 | 1.410 |
Why?
|
Health Expenditures | 4 | 2021 | 170 | 1.260 |
Why?
|
United States | 30 | 2023 | 7367 | 0.940 |
Why?
|
Retrospective Studies | 27 | 2023 | 7277 | 0.920 |
Why?
|
Health Care Costs | 6 | 2018 | 346 | 0.880 |
Why?
|
Patient Portals | 1 | 2022 | 12 | 0.820 |
Why?
|
Organ Dysfunction Scores | 1 | 2021 | 13 | 0.790 |
Why?
|
Medicaid | 4 | 2021 | 302 | 0.790 |
Why?
|
Community Health Workers | 1 | 2021 | 32 | 0.780 |
Why?
|
Humans | 73 | 2023 | 68618 | 0.780 |
Why?
|
Depression | 4 | 2022 | 943 | 0.760 |
Why?
|
Rural Population | 3 | 2021 | 398 | 0.740 |
Why?
|
Exercise | 2 | 2017 | 658 | 0.730 |
Why?
|
Insurance, Health | 3 | 2018 | 201 | 0.720 |
Why?
|
Female | 49 | 2023 | 38074 | 0.710 |
Why?
|
Telemedicine | 4 | 2022 | 700 | 0.700 |
Why?
|
Population Health | 1 | 2020 | 12 | 0.690 |
Why?
|
Ambulatory Care | 3 | 2022 | 340 | 0.690 |
Why?
|
Stroke Rehabilitation | 3 | 2022 | 335 | 0.670 |
Why?
|
Male | 47 | 2023 | 37321 | 0.660 |
Why?
|
Hospitalization | 6 | 2021 | 978 | 0.660 |
Why?
|
Aged | 25 | 2022 | 14862 | 0.650 |
Why?
|
Rehabilitation Centers | 2 | 2018 | 46 | 0.650 |
Why?
|
Hearing Aids | 1 | 2019 | 34 | 0.650 |
Why?
|
Time-to-Treatment | 2 | 2019 | 117 | 0.650 |
Why?
|
Adrenal Cortex Hormones | 2 | 2017 | 186 | 0.650 |
Why?
|
Documentation | 1 | 2019 | 83 | 0.640 |
Why?
|
Nurses | 1 | 2019 | 53 | 0.640 |
Why?
|
Medical History Taking | 1 | 2019 | 94 | 0.640 |
Why?
|
Health Resources | 2 | 2018 | 76 | 0.640 |
Why?
|
Frail Elderly | 1 | 2018 | 31 | 0.620 |
Why?
|
Frailty | 1 | 2018 | 34 | 0.600 |
Why?
|
Risk Adjustment | 1 | 2017 | 49 | 0.590 |
Why?
|
Brain Ischemia | 3 | 2020 | 665 | 0.580 |
Why?
|
Logistic Models | 11 | 2021 | 1420 | 0.570 |
Why?
|
Spouses | 1 | 2016 | 51 | 0.540 |
Why?
|
Aftercare | 1 | 2017 | 114 | 0.530 |
Why?
|
Health Services | 1 | 2016 | 87 | 0.510 |
Why?
|
Child | 16 | 2023 | 6405 | 0.510 |
Why?
|
Aged, 80 and over | 11 | 2019 | 4848 | 0.500 |
Why?
|
Dementia | 1 | 2016 | 158 | 0.490 |
Why?
|
Thrombolytic Therapy | 4 | 2020 | 233 | 0.490 |
Why?
|
Outpatients | 1 | 2015 | 127 | 0.490 |
Why?
|
Nutrition Surveys | 1 | 2016 | 208 | 0.480 |
Why?
|
Surveys and Questionnaires | 8 | 2020 | 2800 | 0.470 |
Why?
|
Dexamethasone | 1 | 2014 | 150 | 0.450 |
Why?
|
Deglutition Disorders | 4 | 2022 | 297 | 0.440 |
Why?
|
Propensity Score | 3 | 2018 | 117 | 0.430 |
Why?
|
Critical Care | 3 | 2021 | 263 | 0.420 |
Why?
|
Longitudinal Studies | 4 | 2020 | 1054 | 0.420 |
Why?
|
Middle Aged | 29 | 2021 | 21147 | 0.410 |
Why?
|
Disability Evaluation | 4 | 2018 | 298 | 0.410 |
Why?
|
Anti-Inflammatory Agents | 1 | 2014 | 234 | 0.410 |
Why?
|
C-Reactive Protein | 1 | 2013 | 180 | 0.400 |
Why?
|
Firearms | 2 | 2023 | 26 | 0.400 |
Why?
|
Wounds, Gunshot | 2 | 2023 | 48 | 0.400 |
Why?
|
Quality Improvement | 4 | 2021 | 413 | 0.390 |
Why?
|
Child, Preschool | 7 | 2021 | 3187 | 0.380 |
Why?
|
Tissue Plasminogen Activator | 4 | 2020 | 296 | 0.380 |
Why?
|
Lipids | 1 | 2013 | 298 | 0.380 |
Why?
|
Adolescent | 16 | 2023 | 8912 | 0.370 |
Why?
|
Emergency Service, Hospital | 5 | 2021 | 711 | 0.370 |
Why?
|
Risk Factors | 9 | 2022 | 5731 | 0.370 |
Why?
|
Amphetamine-Related Disorders | 4 | 2012 | 92 | 0.370 |
Why?
|
Databases, Factual | 5 | 2020 | 622 | 0.340 |
Why?
|
Multivariate Analysis | 6 | 2019 | 1046 | 0.340 |
Why?
|
Insurance Claim Review | 2 | 2019 | 39 | 0.320 |
Why?
|
Republic of Korea | 3 | 2018 | 23 | 0.320 |
Why?
|
Respiratory Insufficiency | 2 | 2021 | 76 | 0.320 |
Why?
|
Patient Transfer | 2 | 2021 | 86 | 0.310 |
Why?
|
Hospitals | 3 | 2020 | 265 | 0.300 |
Why?
|
Practice Patterns, Physicians' | 4 | 2022 | 504 | 0.290 |
Why?
|
Independent Living | 2 | 2018 | 44 | 0.290 |
Why?
|
Adult | 24 | 2022 | 21403 | 0.280 |
Why?
|
Activities of Daily Living | 3 | 2017 | 319 | 0.280 |
Why?
|
Cross-Sectional Studies | 9 | 2022 | 2279 | 0.280 |
Why?
|
Fibrinolytic Agents | 3 | 2020 | 377 | 0.280 |
Why?
|
Gastrostomy | 2 | 2018 | 110 | 0.270 |
Why?
|
Comorbidity | 4 | 2018 | 1426 | 0.260 |
Why?
|
Enteral Nutrition | 2 | 2018 | 157 | 0.260 |
Why?
|
Guideline Adherence | 3 | 2019 | 287 | 0.250 |
Why?
|
Psychometrics | 5 | 2020 | 514 | 0.250 |
Why?
|
Infant | 4 | 2021 | 2891 | 0.250 |
Why?
|
Intensive Care Units | 3 | 2021 | 344 | 0.250 |
Why?
|
Corticotropin-Releasing Hormone | 3 | 2010 | 79 | 0.240 |
Why?
|
Bariatric Surgery | 2 | 2016 | 90 | 0.240 |
Why?
|
Time Factors | 5 | 2020 | 4655 | 0.240 |
Why?
|
Treatment Outcome | 8 | 2020 | 7029 | 0.240 |
Why?
|
Cohort Studies | 6 | 2023 | 2358 | 0.230 |
Why?
|
Substance-Related Disorders | 3 | 2023 | 1242 | 0.220 |
Why?
|
Obesity, Morbid | 2 | 2016 | 172 | 0.220 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 772 | 0.220 |
Why?
|
Quality of Life | 5 | 2022 | 1515 | 0.210 |
Why?
|
Upper Extremity | 3 | 2022 | 112 | 0.210 |
Why?
|
Electronic Prescribing | 1 | 2022 | 9 | 0.210 |
Why?
|
Adrenocorticotropic Hormone | 4 | 2010 | 106 | 0.200 |
Why?
|
Endovascular Procedures | 2 | 2017 | 366 | 0.200 |
Why?
|
Medical Order Entry Systems | 1 | 2021 | 24 | 0.200 |
Why?
|
Opioid-Related Disorders | 2 | 2020 | 298 | 0.200 |
Why?
|
South Carolina | 7 | 2020 | 2752 | 0.190 |
Why?
|
Monte Carlo Method | 1 | 2021 | 124 | 0.190 |
Why?
|
Length of Stay | 4 | 2017 | 780 | 0.190 |
Why?
|
Vulnerable Populations | 1 | 2021 | 84 | 0.190 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2021 | 20 | 0.190 |
Why?
|
Leadership | 2 | 2020 | 136 | 0.180 |
Why?
|
Pituitary-Adrenal System | 3 | 2010 | 138 | 0.180 |
Why?
|
Mental Health Services | 1 | 2023 | 199 | 0.180 |
Why?
|
Hydrocortisone | 4 | 2010 | 291 | 0.180 |
Why?
|
Decision Support Systems, Clinical | 1 | 2021 | 88 | 0.180 |
Why?
|
Analgesics, Opioid | 2 | 2020 | 498 | 0.180 |
Why?
|
Prospective Studies | 3 | 2019 | 3705 | 0.180 |
Why?
|
Cocaine-Related Disorders | 3 | 2010 | 504 | 0.180 |
Why?
|
Sex Characteristics | 4 | 2011 | 295 | 0.180 |
Why?
|
Data Interpretation, Statistical | 2 | 2019 | 329 | 0.180 |
Why?
|
Patient Acceptance of Health Care | 2 | 2023 | 468 | 0.180 |
Why?
|
Health Services Accessibility | 2 | 2021 | 581 | 0.170 |
Why?
|
Sex Factors | 6 | 2016 | 1266 | 0.170 |
Why?
|
Erythrocyte Transfusion | 1 | 2020 | 72 | 0.170 |
Why?
|
Emergency Medicine | 1 | 2020 | 88 | 0.170 |
Why?
|
Administration, Inhalation | 2 | 2017 | 187 | 0.170 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2020 | 77 | 0.170 |
Why?
|
Hearing Tests | 1 | 2020 | 70 | 0.170 |
Why?
|
Opiate Substitution Treatment | 1 | 2020 | 57 | 0.170 |
Why?
|
Family Practice | 1 | 2022 | 312 | 0.170 |
Why?
|
Critical Illness | 1 | 2021 | 191 | 0.170 |
Why?
|
Pregnant Women | 1 | 2020 | 50 | 0.170 |
Why?
|
Speech Reception Threshold Test | 1 | 2019 | 25 | 0.170 |
Why?
|
Perioperative Care | 1 | 2020 | 100 | 0.170 |
Why?
|
Datasets as Topic | 1 | 2019 | 53 | 0.170 |
Why?
|
School Health Services | 1 | 2019 | 72 | 0.170 |
Why?
|
Coronary Artery Bypass | 1 | 2020 | 218 | 0.160 |
Why?
|
Audiometry, Pure-Tone | 1 | 2019 | 96 | 0.160 |
Why?
|
Buprenorphine | 1 | 2020 | 67 | 0.160 |
Why?
|
Behavior, Addictive | 3 | 2012 | 317 | 0.160 |
Why?
|
Family | 1 | 2021 | 293 | 0.160 |
Why?
|
Statistics, Nonparametric | 1 | 2019 | 306 | 0.160 |
Why?
|
Health Surveys | 2 | 2018 | 489 | 0.160 |
Why?
|
Hip Fractures | 1 | 2019 | 26 | 0.160 |
Why?
|
Stress, Psychological | 3 | 2010 | 824 | 0.160 |
Why?
|
Presbycusis | 1 | 2020 | 84 | 0.160 |
Why?
|
Physicians, Women | 1 | 2018 | 23 | 0.160 |
Why?
|
Models, Statistical | 3 | 2018 | 448 | 0.160 |
Why?
|
Staff Development | 1 | 2018 | 35 | 0.160 |
Why?
|
Cognition Disorders | 2 | 2012 | 342 | 0.160 |
Why?
|
Patient Admission | 1 | 2019 | 99 | 0.160 |
Why?
|
Patient Reported Outcome Measures | 1 | 2019 | 114 | 0.160 |
Why?
|
Risk Assessment | 3 | 2020 | 2007 | 0.160 |
Why?
|
Community Health Services | 1 | 2019 | 141 | 0.160 |
Why?
|
Physicians | 1 | 2022 | 324 | 0.160 |
Why?
|
Polypharmacy | 1 | 2018 | 31 | 0.160 |
Why?
|
Osteoporosis | 1 | 2019 | 88 | 0.150 |
Why?
|
Inappropriate Prescribing | 1 | 2018 | 27 | 0.150 |
Why?
|
Socioeconomic Factors | 2 | 2018 | 955 | 0.150 |
Why?
|
Echocardiography | 1 | 2021 | 515 | 0.150 |
Why?
|
Emergency Medical Services | 1 | 2020 | 225 | 0.150 |
Why?
|
Skilled Nursing Facilities | 1 | 2018 | 30 | 0.150 |
Why?
|
Patient Discharge | 2 | 2017 | 294 | 0.150 |
Why?
|
Intubation, Gastrointestinal | 1 | 2018 | 48 | 0.150 |
Why?
|
Faculty, Medical | 1 | 2018 | 110 | 0.150 |
Why?
|
Cost Savings | 2 | 2017 | 110 | 0.150 |
Why?
|
Risk | 2 | 2017 | 563 | 0.150 |
Why?
|
Age Factors | 4 | 2016 | 1864 | 0.150 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2019 | 189 | 0.140 |
Why?
|
Chronic Disease | 1 | 2021 | 1330 | 0.140 |
Why?
|
Regression Analysis | 2 | 2017 | 737 | 0.140 |
Why?
|
Drug Utilization | 1 | 2017 | 119 | 0.140 |
Why?
|
Academic Medical Centers | 1 | 2018 | 281 | 0.140 |
Why?
|
Gastroscopy | 1 | 2016 | 45 | 0.140 |
Why?
|
Healthcare Disparities | 1 | 2020 | 378 | 0.140 |
Why?
|
Cues | 5 | 2012 | 654 | 0.130 |
Why?
|
History, 21st Century | 1 | 2016 | 127 | 0.130 |
Why?
|
Overweight | 1 | 2017 | 186 | 0.130 |
Why?
|
Cost Control | 1 | 2015 | 34 | 0.130 |
Why?
|
Musculoskeletal Diseases | 1 | 2016 | 45 | 0.130 |
Why?
|
Bacteriological Techniques | 1 | 2015 | 49 | 0.130 |
Why?
|
Physical Therapy Modalities | 1 | 2016 | 133 | 0.130 |
Why?
|
Community-Acquired Infections | 1 | 2015 | 46 | 0.130 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2016 | 75 | 0.130 |
Why?
|
Health Behavior | 1 | 2019 | 458 | 0.130 |
Why?
|
Patient Readmission | 1 | 2018 | 267 | 0.130 |
Why?
|
Body Weight | 1 | 2017 | 554 | 0.130 |
Why?
|
Physical Examination | 1 | 2016 | 152 | 0.120 |
Why?
|
Pneumonia | 1 | 2015 | 110 | 0.120 |
Why?
|
Self Care | 1 | 2017 | 253 | 0.120 |
Why?
|
Heart Rate | 4 | 2010 | 568 | 0.120 |
Why?
|
Tertiary Care Centers | 1 | 2014 | 67 | 0.120 |
Why?
|
Health Personnel | 1 | 2017 | 286 | 0.120 |
Why?
|
Parents | 1 | 2017 | 312 | 0.120 |
Why?
|
Reproducibility of Results | 5 | 2017 | 2077 | 0.120 |
Why?
|
Odds Ratio | 1 | 2016 | 880 | 0.120 |
Why?
|
Veterans | 2 | 2019 | 904 | 0.120 |
Why?
|
Analysis of Variance | 1 | 2017 | 1040 | 0.120 |
Why?
|
Coronary Artery Disease | 1 | 2020 | 696 | 0.120 |
Why?
|
Forecasting | 1 | 2015 | 277 | 0.120 |
Why?
|
Recurrence | 1 | 2017 | 948 | 0.120 |
Why?
|
Aphasia | 2 | 2014 | 119 | 0.110 |
Why?
|
Anesthesia, General | 1 | 2014 | 86 | 0.110 |
Why?
|
Quality Indicators, Health Care | 1 | 2014 | 136 | 0.110 |
Why?
|
Bacteremia | 1 | 2015 | 155 | 0.110 |
Why?
|
Caregivers | 1 | 2016 | 365 | 0.110 |
Why?
|
Sepsis | 1 | 2016 | 233 | 0.110 |
Why?
|
Models, Theoretical | 1 | 2016 | 384 | 0.110 |
Why?
|
Recovery of Function | 3 | 2022 | 506 | 0.100 |
Why?
|
Affective Symptoms | 1 | 2012 | 50 | 0.100 |
Why?
|
Prevalence | 1 | 2016 | 1619 | 0.100 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2009 | 150 | 0.100 |
Why?
|
Motivation | 2 | 2012 | 561 | 0.090 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2021 | 1506 | 0.090 |
Why?
|
Epilepsy | 1 | 2014 | 336 | 0.090 |
Why?
|
Severity of Illness Index | 1 | 2016 | 1851 | 0.090 |
Why?
|
Child Abuse | 2 | 2010 | 186 | 0.090 |
Why?
|
Aging | 1 | 2016 | 911 | 0.090 |
Why?
|
Smoking | 2 | 2009 | 1452 | 0.090 |
Why?
|
Electroencephalography | 2 | 2022 | 418 | 0.080 |
Why?
|
Drug Prescriptions | 1 | 2010 | 135 | 0.080 |
Why?
|
Social Environment | 1 | 2010 | 182 | 0.080 |
Why?
|
Program Development | 2 | 2020 | 240 | 0.080 |
Why?
|
Methamphetamine | 1 | 2010 | 132 | 0.080 |
Why?
|
Antidepressive Agents | 1 | 2009 | 216 | 0.080 |
Why?
|
Cognition | 1 | 2011 | 513 | 0.070 |
Why?
|
Cause of Death | 2 | 2021 | 241 | 0.070 |
Why?
|
Biomarkers | 1 | 2013 | 1593 | 0.070 |
Why?
|
Stress, Physiological | 1 | 2008 | 215 | 0.070 |
Why?
|
Florida | 2 | 2017 | 221 | 0.070 |
Why?
|
Infant, Newborn | 2 | 2021 | 2455 | 0.060 |
Why?
|
Cost-Benefit Analysis | 2 | 2017 | 504 | 0.060 |
Why?
|
Prognosis | 2 | 2022 | 2093 | 0.060 |
Why?
|
Hospital Costs | 2 | 2014 | 117 | 0.060 |
Why?
|
Infusions, Intravenous | 2 | 2017 | 334 | 0.050 |
Why?
|
Young Adult | 4 | 2019 | 5717 | 0.050 |
Why?
|
Barium | 1 | 2022 | 52 | 0.050 |
Why?
|
Blood Pressure | 1 | 2008 | 1451 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2021 | 3259 | 0.050 |
Why?
|
Ambulatory Care Facilities | 1 | 2022 | 91 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 1753 | 0.050 |
Why?
|
Hospitals, Community | 1 | 2020 | 64 | 0.050 |
Why?
|
Hospitals, Rural | 1 | 2020 | 43 | 0.040 |
Why?
|
Photic Stimulation | 2 | 2012 | 229 | 0.040 |
Why?
|
Non-Randomized Controlled Trials as Topic | 1 | 2020 | 19 | 0.040 |
Why?
|
Interdisciplinary Communication | 1 | 2020 | 93 | 0.040 |
Why?
|
Deglutition | 1 | 2022 | 221 | 0.040 |
Why?
|
Personality Inventory | 2 | 2012 | 197 | 0.040 |
Why?
|
Medical Audit | 1 | 2019 | 44 | 0.040 |
Why?
|
Neuropsychological Tests | 2 | 2012 | 517 | 0.040 |
Why?
|
Comparative Effectiveness Research | 1 | 2019 | 36 | 0.040 |
Why?
|
Factor Analysis, Statistical | 1 | 2019 | 201 | 0.040 |
Why?
|
Evidence-Based Practice | 1 | 2020 | 146 | 0.040 |
Why?
|
Hearing | 1 | 2020 | 133 | 0.040 |
Why?
|
Mental Health | 1 | 2021 | 278 | 0.040 |
Why?
|
Neuronal Plasticity | 1 | 2022 | 274 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2022 | 442 | 0.040 |
Why?
|
Career Mobility | 1 | 2018 | 34 | 0.040 |
Why?
|
Pandemics | 1 | 2022 | 352 | 0.040 |
Why?
|
Incidence | 1 | 2022 | 1603 | 0.040 |
Why?
|
Career Choice | 1 | 2018 | 98 | 0.040 |
Why?
|
Area Under Curve | 1 | 2018 | 238 | 0.040 |
Why?
|
Quality-Adjusted Life Years | 1 | 2017 | 106 | 0.040 |
Why?
|
Europe | 1 | 2017 | 196 | 0.040 |
Why?
|
ROC Curve | 1 | 2018 | 392 | 0.040 |
Why?
|
Registries | 1 | 2020 | 733 | 0.030 |
Why?
|
Canada | 1 | 2017 | 267 | 0.030 |
Why?
|
Australia | 1 | 2017 | 235 | 0.030 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2018 | 171 | 0.030 |
Why?
|
Hospitals, Pediatric | 1 | 2017 | 114 | 0.030 |
Why?
|
Program Evaluation | 1 | 2018 | 502 | 0.030 |
Why?
|
Respiration, Artificial | 1 | 2017 | 190 | 0.030 |
Why?
|
Perception | 1 | 2017 | 189 | 0.030 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2016 | 73 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2016 | 85 | 0.030 |
Why?
|
Likelihood Functions | 1 | 2016 | 106 | 0.030 |
Why?
|
Morbidity | 1 | 2015 | 130 | 0.030 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 546 | 0.030 |
Why?
|
Observer Variation | 1 | 2016 | 330 | 0.030 |
Why?
|
United States Department of Veterans Affairs | 1 | 2016 | 307 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 951 | 0.030 |
Why?
|
Dysarthria | 1 | 2014 | 9 | 0.030 |
Why?
|
Urban Health | 1 | 2014 | 49 | 0.030 |
Why?
|
Pregnancy | 1 | 2020 | 2334 | 0.030 |
Why?
|
Rural Health | 1 | 2014 | 66 | 0.030 |
Why?
|
Decision Support Techniques | 1 | 2015 | 191 | 0.030 |
Why?
|
Body Mass Index | 1 | 2017 | 867 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2014 | 193 | 0.030 |
Why?
|
Cost of Illness | 1 | 2014 | 206 | 0.030 |
Why?
|
Acute Disease | 1 | 2014 | 658 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2014 | 252 | 0.030 |
Why?
|
Computer Simulation | 1 | 2016 | 706 | 0.030 |
Why?
|
Individuality | 1 | 2012 | 44 | 0.030 |
Why?
|
Reaction Time | 1 | 2012 | 170 | 0.020 |
Why?
|
Motor Skills | 1 | 2011 | 88 | 0.020 |
Why?
|
Demography | 1 | 2011 | 279 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2012 | 213 | 0.020 |
Why?
|
Psychological Tests | 1 | 2010 | 96 | 0.020 |
Why?
|
Galvanic Skin Response | 1 | 2010 | 67 | 0.020 |
Why?
|
Algorithms | 1 | 2016 | 1196 | 0.020 |
Why?
|
Databases, Bibliographic | 1 | 2009 | 14 | 0.020 |
Why?
|
Long-Term Care | 1 | 2009 | 53 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2015 | 1026 | 0.020 |
Why?
|
Arousal | 1 | 2009 | 168 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2009 | 291 | 0.020 |
Why?
|
Life Change Events | 1 | 2009 | 223 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2010 | 782 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2011 | 1465 | 0.020 |
Why?
|
Patient Selection | 1 | 2010 | 592 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2009 | 1738 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2009 | 931 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2009 | 1553 | 0.020 |
Why?
|
Research Design | 1 | 2008 | 729 | 0.010 |
Why?
|